Guests

has a Bachelor´s degree in Biomedical Sciences (UNESP, Botucatu), Master's degree at the University of São Paulo (USP) and PhD at Federal University of São Paulo (UNIFESP, Brazil). He is an Associate Professor of Microbiology at the Institute of Biosciences (São Paulo State University, Brazil). His main research topic focuses on the study of epidemiological and pathogenic aspects of diarrheagenic Escherichia coli, with emphasis on genomics.

holds a degree in Biological Sciences (University of São Paulo, USP), Master’s and PhD degrees in Microbiology and Immunology (Escola Paulista de Medicina, Federal University of São Paulo, UNIFESP, Brazil). Retired Associate Professor of the Department of Microbiology, Immunology and Parasitology, UNIFESP. Main research contributions are related to the epidemiology, pathogenicity, and analysis of genetic similarity of Shiga toxin-producing Escherichia coli (STEC) isolated from different sources: humans, animals and foods.

is a veterinarian and holds a PhD in agricultural and forestry sciences from the University of Chile. He is currently an Assistant Professor in the Department of Preventive Medicine at the Faculty of Veterinary and Animal Sciences (University of Chile). His research focuses on the epidemiological and molecular characterization of STEC and its molecular interaction with the bovine host.

PhD. MS. is the Herman Barnett Distinguished Professor in Microbiology and Immunology at UTMB. He is a peer-recognized bacteriologist/vaccinologist with extensive experience in the study of bacterial pathogens causing diarrheal disease, such as pathogenic Escherichia coli or Shigella, or biodefense-related organisms, such as pathogenic Burkholderia species. He is the founder and current coordinator of the Latin American Coalition for Escherichia coli Research (LACER).

is a Biochemistry (University of Buenos Aires) and Master in Molecular Microbiology (San Martin University-ANLIS Dr. Carlos G. Malbrán Institute Argentina). Head of the National Reference Laboratory for diarrheagenic E. coli infections (Servicio Fisiopatogenia, Bacteriology Department at INEI-ANLIS Malbrán) and coordinator of the Argentine Network of Diarrhea and Foodborne Bacterial Pathogens. She actively participates in the surveillance of these diseases and is dedicated to the implementation and validation of new molecular techniques for the diagnosis of DEC/STEC.

is a Biochemistry (University of Buenos Aires , UBA), Master of Public Health (UNSAM). Former Head of the Servicio Fisiopatogenia (INEI-ANLIS Malbrán), National Reference Laboratory for Hemolytic Uremic Syndrome and E. coli Infections of Argentina. Former Professor of Microbiology (UBA), and Associate Professor of Microbiology and Food Microbiology (UADE). Currently, Advisor at INMUNOVA.

holds a PhD  degree in Biochemistry (University of Buenos Aires). She specialized in Immunology, working at the National Academy of Medicine as a member of National Council for Scientific and Technological Research (CONICET). She is a Senior Researcher at CONICET. Her research focuses on the inflammatory response in the progression of infections with Shiga toxin-producing E. coli, towards the severe systemic forms, mainly Hemolytic Uremic Syndrome (HUS). She also has studied the adaptive response as the main protective factor that prevents the recurrence of this disease and as the basis for putative preventive or therapeutic treatments against HUS.

has a Bachelor´s degree in Biomedical Sciences (Escola Paulista de Medicina, EPM), Master’s and PhD degrees in Microbiology and Immunology (EPM). Is a Full Professor of Microbiology in the Department of Microbiology, Immunology, and Parasitology at EPM, Federal University of São Paulo, Brazil. Her research interests focus on the genetic diversity, bacterial pathogenicity, epidemiology, and antimicrobial resistance of Escherichia coli strains involved in diarrheal diseases and extraintestinal E. coli, hybrid E. coli strains, and Escherichia albertii.

studied biology at the University of Göttingen (Germany) and obtained his PhD from the University of Würzburg (Germany). Former research associate and group leader at the Institute of Molecular Infection Biology (Würzburg). Presently is a Full Professor and Director of the section Microbial Genome Plasticity at the Institute of Hygiene, University of Münster. His research focuses on understanding bacterial variability at the genetic and phenotypic levels, and its implications for adaptational processes, fitness, and pathogenesis. He is engaged in studies on bacterium-host interactions at the molecular level by applying different infection models, as well as on the evolution and spread of mobile genetic elements in Escherichia coli and related enterobacteria.

has BSc in Biology, Faculty of Life Sciences (Tel Aviv University) and PhD in Structural Biology, School of Medicine (University of Buenos Aires). He is an Independent Researcher at the National Council for Scientific and Technical Research (CONICET) and is an Assistant Professor of Human Physiology at the Institute of Physiology and Biophysics, School of Medicine (University of Buenos Aires). He has conducted extensive research based on alterations in the Central Nervous System, ranging from cellular to behavioral perspectives. Presently, his team focus on investigating the neurological changes associated with encephalopathy resulting from Shiga toxin (Stx) contamination due to enterohemorrhagic E. coli (STEC).

has a Bachelor´s degree in Biomedical Sciences (University of Mogi das Cruzes, São Paulo), Master´s and Doctoral degrees in Microbiology (Escola Paulista de Medicina, Federal University of São Paulo, Brazil). He is currently a Scientific Researcher in the Bacteriology Laboratory at Butantan Institute. He has been working in the field of bacterial pathogenicity, with major interests in diarrheagenic Escherichia coli pathotypes, including epidemiology, diagnosis, mechanisms of pathogenicity and characterization of virulence factors.

Licenciate in Physical Chemistry and Biochemistry (Córdoba, University), and PhD in Biochemistry (University of Buenos Aires, UBA). Retired Professor of Physiology and Biophysic at the Facultad de Ciencias Médicas (UBA). Senior Researcher in the Institute of Physiology and Biophysic of the Argentine Research Council (IFIBIO-CONICET) and Member of the Scientific Committee at the Joint Center S&T of the Chinese Academy of Sciences (CAS) and CONICET. Her research interests are the physiopathology of Hemolytic Uremic Syndrome caused by enterohemorrhagic Escherichia coli.

is a Biochemistry (University of Buenos Aires, UBA), and PhD in Chemistry (UBA). Currently, he worked at the Institute of Biotechnology of the Agricultural Research Institution of Argentina (INTA) where he contributed to the design and consolidation of lines of research on vaccines and diagnostics focused on veterinary and zoonotic diseases. He mostly works on Mycobacterium bovis, the agent of bovine TB and enterohemorhagic E. coli. It has the highest research category in the INTA and is Superior Investigator of CONICET.

has a bachelor's degree in Biological Sciences (State University of Ponta Grossa), Master's degree in Microbiology (University of São Paulo), and PhD in Sciences (Butantan Institute). She is a full-time researcher at the Antibody Development Center, Bacteriology Laboratory (Butantan Institute). She conducts research on recombinant antibodies as biopharmaceuticals and diagnostic tools.

holds a degree in Pharmacy and Biochemistry (Federal University of Santa Catarina), Master’s degree in Pharmacy - Clinical Analysis (University of São Paulo), and PhD in Sciences (University of São Paulo). She is a Scientific Researcher at the Bacteriology Laboratory/Antibody Development Center (Butantan Institute). Her research expertise lies in Microbiology, with a focus on Pathogenicity and Bacterial Diagnosis. Her primary research line involves the production of polyclonal, monoclonal, and recombinant antibodies against virulence factors of diarrheagenic Escherichia coli and the development of immunological methods for diagnosing emerging and re-emerging pathogens.

holds a Bachelor's degree in Biological Sciences, as well as Master's and PhD degrees in Molecular Genetics (State University of Campinas). Additionally, she completed a PhD and postdoctoral research at the University of Maryland School of Medicine (Baltimore, MD). Research in her laboratory investigates chemical, stress and nutritional signaling at the interface amongst the mammalian host, beneficial microbiota and invading pathogens. The main research is the study of how bacterial cells sense several mammalian neurotransmitters as a means to gauge the physiological and immune state of the host, leading to rewiring and reprogramming of bacterial transcription towards host and niche adaptation.

has a PhD in Biological Sciences (University of Buenos Aires, UBA). She is an Independent Researcher at the National Council of Scientific Research (CONICET) and an Assistant Professor of Physiology at the School of Medicine (UBA). She works at the Laboratory of Physiopathogenesis at the Institute of Physiology and Biophysics "Bernardo Houssay" (IFIBIO-Houssay), School of Medicine. She specializes in studying STEC-HUS pathogenesis and analyzing different therapeutic strategies to prevent kidney damage caused by the Shiga toxin.

is a Biochemistry and then developed her PhD thesis regarding the effects of Shiga toxin type 2 during early pregnancy. She is an Associate Researcher at CONICET (National Council for Scientific and Technical Research, Argentina) and Assistant Professor of Physiology and Biophysics at the School of Medicine (University of Buenos Aires). Her research topic focuses on innovative developments for the diagnosis, treatment, and prevention of Hemolytic Uremic Syndrome caused by Shiga toxin-producing Escherichia coli.

holds a degree in Biomedical Sciences and a PhD in Microbiology and Immunology at Escola Paulista de Medicina, Federal University of São Paulo (EPM-UNIFESP, Brazil). He is a Microbiology Researcher at Adolfo Lutz Institute, which is a Brazilian Reference Laboratory for Diarrheagenic E. coli and Hemolytic Uremic Syndrome. The main focus of his work is the diagnosis and surveillance of food and waterborne diseases, with emphasis on diarrheagenic Escherichia coli pathotypes and Shigella spp.

is a researcher at CONICET and conducts work at the Antimicrobial Division, National Institute of Infectious Diseases - ANLIS – Malbrán in Argentina. Her research focuses on the molecular epidemiology of emerging mechanisms of resistance as well as the dissemination strategies of Gram-negative bacteria with a One Health perspective.

has PhD in Biomedical Sciences (University of Chile). His research/diagnostic laboratories combine cell biology, microbiology, and bioinformatics focused on host factors involved in the adherence of diarrheagenic Escherichia coli (DEC) to intestinal epithelial cells and the role of this binding in the inflammation process mediated by these pathogens. Currently, his research is focused on the role of gut microbiota and its metabolites in the virulence regulation of DEC.  In the clinical research setting, our laboratory focuses on applying molecular diagnostic techniques to clinical microbiology in immunocompromised pediatric patients.

is a microbiologist specializing in zoonotic pathogens, with focus on enterohemorrhagic Escherichia coli (EHEC) O157:H7. He leads the EHEC research group at IABIMO INTA-CONICET (Argentina), and has developed vaccine candidates with applications in animal health and food safety. His research aligns with the One Health approach, aiming to reduce human disease through innovations in veterinary microbiology.

is a biotechnologist with a PhD in Basic and Applied Sciences (National University of Quilmes, UNQ). She specializes in Shiga toxin, focusing on innovative therapeutic strategies for Hemolytic Uremic Syndrome (HUS) and bacteriophages and endolysins. Her research has included multidrug-resistant bacteria such as Acinetobacter baumannii, Staphylococcus aureus, Streptococcus agalactiae and Pseudomonas aeruginosa. She is an Independent Researcher at CONICET based at José C. Paz National University (UNPAZ), and a lecturer at UNQ.

is a Principal Researcher from CONICET (Argentina National Research Council) at the Instituto de Medicina Experimental (IMEX)-CONICET, National Academy of Medicine, where she directs the Innate Immunity Laboratory. Professor of Immunology at the Faculty of Medicine (University of Buenos Aires). Her group has contributed to the understanding of neutrophil responses to infections and tissue damage.

has participated in reference activities for the diagnosis of Shiga toxin-producing Escherichia coli and diarrheagenic Escherichia coli in the National Reference Laboratory for diarrheagenic E. coli infections (Servicio Fisiopatogenia, Bacteriology Department at the National Institute of Infectious Diseases ANLIS Dr. Carlos G. Malbrán, Argentina). She has worked on the implementation of new technologies for whole-genome sequencing and the evaluation of algorithms for bioinformatics analysis and diagnosis. She also coordinates technical activities within the PulseNet Latin America and the Caribbean network in the framework of regional surveillance of foodborne bacterial pathogens.

specialist in Bacteriology-Mycology, Master’s Degree in Bacteriology-Mycology at Pedro Kourí Institute of Tropical Medicine (IPK), and Medical Doctor. Head of the National Reference Laboratory (LNR-EDA-IPK) Cuba.  Currently he is an Auxiliary Professor and Researcher at IPK.  Main interests are overseeing diagnostic standards, research protocols, and national/international collaborations.

is a pharmacist from UFRGS and holds a PhD in Biochemistry from the University of Oxford. Since 2000, she has been studying extraintestinal pathogenic strains of E. coli, focusing on strains that cause avian colibacillosis and meningitis in newborns. She is a professor and researcher affiliated with the Department of Biophysics (Institute of Biosciences) at UFRGS.

works at the Laboratory of Pathogenesis and Immunology of Infectious Processes, Institute of Experimental Medicine (IMEX) CONICET, National Academy of Medicine. Specialized in host-pathogen interactions in EHEC infections, from the perspective of the bacterial pathogenicity, its interaction with other pathogens/probiotics, and the mucosal immune response in the host

is a biologist (National Autonomous University of Mexico), with a master’s and PhD in Cell Biology from the Faculty of Sciences at UNAM. He completed a postdoctoral fellowship at the Center for Vaccine Development at the School of Medicine at the University of Maryland, Baltimore, USA. He is a professor/researcher at the Department of Cell Biology at CINVESTAV-IPN, Mexico City. His scientific research focuses on the role of the intestinal epithelium during bacterial infections (mucosal pathogenesis and immunity). Specifically, he focuses on the interaction between epithelial cells and enteropathogens; Cellular Microbiology.

has a biology bachelor´s and master’s degree from the National Polytechnic Institute (IPN), Mexico, and a Biological Science PhD from the University of Birmingham. Currently, she is a Professor at the CINVESTAV-IPN, and has worked on developing diagnostics methods for the identification of the six diarrheagenic E. coli pathotypes and she is a member by invitation of two WHO committees.

is a Professor in the Department of Microbiology at Southern Medical University. He holds degrees from Central China Normal University in Biological Science), Wuhan Institute of Virology in Virology), and Southern Medical University (Ph.D. in Microbiology). His research expertise lies in the genomics and pathogenesis of EHEC O157:H7.